Genetically Engineered Oncolytic Newcastle Disease Virus Effectively Induces Sustained Remission of Malignant Pleural Mesothelioma. Sep 2010 - :1538-8514 [PMID:20858727] [Silberhumer GR] [Brader P] [Wong J] [Serganova IS] [Gönen M] [Gonzalez SJ] [Blasberg R] [Zamarin D] [Fong Y]
Consolidative dendritic cell-based immunotherapy elicits cytotoxicity against malignant mesothelioma. Jun 2010 - Am. J. Respir. Crit. Care Med.; 181(12):1535-4970 [PMID:20167848] [Hegmans JP] [Veltman JD] [Lambers ME] [de Vries IJ] [Figdor CG] [Hendriks RW] [Hoogsteden HC] [Lambrecht BN] [Aerts JG]
Laboratory and clinical basis for hyperthermia as a component of intracavitary chemotherapy. Aug 2007 - Int J Hyperthermia; 23(5):0265-6736 [PMID:17701534] [Sugarbaker PH]
[Malignant peritoneal mesothelioma. Our experienced with triple combined therapy: cytoreduction, intraperitoneal perioperative chemotherapy and hyperthermia] Feb 2007 - Cir Esp; 81(2):0009-739X [PMID:17306123] [Gómez Portilla A] [Cendoya I] [Muriel J] [Olabarria I] [Guede N] [Moraza N] [Fernández E] [Martínez de Lecea C] [Magrach L] [Martín E] [Romero E] [Aguado I] [Valdovinos M] [Larrabide I]
[Immunotherapy and malignant mesothelioma: clinical perspectives] Jan 2007 - Bull Cancer; 94(1):1769-6917 [PMID:17237002] [Grégoire M] [Ebstein F]
Hyperthermia combined with intra-thoracic chemotherapy and radiotherapy for malignant pleural mesothelioma. Nov 2006 - Int J Hyperthermia; 22(7):0265-6736 [PMID:17079218] [Xia H] [Karasawa K] [Hanyu N] [Chang TC] [Okamoto M] [Kiguchi Y] [Kawakami M] [Itazawa T]
Mesothelioma environment comprises cytokines and T-regulatory cells that suppress immune responses. Jun 2006 - Eur. Respir. J.; 27(6):0903-1936 [PMID:16540497] [Hegmans JP] [Hemmes A] [Hammad H] [Boon L] [Hoogsteden HC] [Lambrecht BN]
Immunotherapy of murine malignant mesothelioma using tumor lysate-pulsed dendritic cells. May 2005 - Am. J. Respir. Crit. Care Med.; 171(10):1073-449X [PMID:15764728] [Hegmans JP] [Hemmes A] [Aerts JG] [Hoogsteden HC] [Lambrecht BN]
Cytotoxic T cell responses against mesothelioma by apoptotic cell-pulsed dendritic cells. Jun 2004 - Am. J. Respir. Crit. Care Med.; 169(12):1073-449X [PMID:15070823] [Ebstein F] [Sapede C] [Royer PJ] [Marcq M] [Ligeza-Poisson C] [Barbieux I] [Cellerin L] [Dabouis G] [Grégoire M]
[Evaluation of the therapeutic benefit of 41.8 degrees C whole body hyperthermia plus ifosfamide, carboplatin and etoposide (ICE) for patients with malignant pleural mesothelioma using the Modified Brunner-Score (MBS)] Apr 2004 - Pneumologie; 58(4):0934-8387 [PMID:15098157] [Bruns I] [Kohlmann T] [Wiedemann GJ] [Bakhshandeh A]
Ifosfamide, carboplatin and etoposide combined with 41.8 degrees C whole body hyperthermia for malignant pleural mesothelioma. Mar 2003 - Lung Cancer; 39(3):0169-5002 [PMID:12609573] [Bakhshandeh A] [Bruns I] [Traynor A] [Robins HI] [Eberhardt K] [Demedts A] [Kaukel E] [Koschel G] [Gatzemeier U] [Kohlmann T] [Dalhoff K] [Ehlers EM] [Gruber Y] [Zumschlinge R] [Hegewisch-Becker S] [Peters SO] [Wiedemann GJ]
[Chemotherapy in combination with whole-body hyperthermia in advanced malignant pleural mesothelioma] Apr 2000 - Dtsch. Med. Wochenschr.; 125(11):0012-0472 [PMID:10761473] [Bakhshandeh A] [Bruns I] [Eberhardt K] [Wiedemann GJ]
